Probiotics and primary prevention of atopic dermatitis: A meta-analysis of randomized controlled studies

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 2, 2015, Pages 232-242

  Panduru, M ^a   Panduru, N M ^a   Selevestru C M ^a   Tiplica, G S ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; BIFIDOBACTERIUM; FOLLOW UP; HUMAN; LACTOBACILLUS; META ANALYSIS; PERINATAL PERIOD; PRENATAL PERIOD; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; DERMATITIS, ATOPIC; DIET THERAPY; DRUG EFFECTS; INFANT; NEWBORN; PROCEDURES; STATISTICS AND NUMERICAL DATA;

BIFIDOBACTERIUM; DERMATITIS, ATOPIC; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS; PRIMARY PREVENTION; PROBIOTICS;

EID: 84921604574     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12496     Document Type: Article

References (46)

1. Spergel JM, Paller AS,. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112 (Suppl 6): S118-S127.
2. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S,. Differences in bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001; 108: 144-145.
3. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S,. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001; 30: 43-47.
4. He F, Morita H, Hashimoto H, et al,. Intestinal bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol 2002; 109: 1035-1036.
5. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
6. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG,. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006; 6: 50. doi: 10.1186/1471-2288-6-50.
7. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E,. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076-1079.
8. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E,. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869-1871.
9. Kalliomaki M, Salminen S, Poussa T, Isolauri E,. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021.
10. Rautava S, Kalliomaki M, Isolauri E,. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-121.
11. Rautava S, Arvilommi H, Isolauri E,. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 2006; 60: 221-224.
12. Rautava S, Kainonen E, Salminen S, Isolauri E,. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130: 1355-1360.
13. Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E,. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy 2008; 38: 1342-1348.
14. Kukkonen K, Savilahti E, Haahtela T, et al,. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 192-198.
15. Kuitunen M, Kukkonen K, Juntunen-Backman K, et al,. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123: 335-341.
16. Abrahamsson TR, Jakobsson T, Bottcher MF, et al,. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1174-1180.
17. Abrahamsson TR, Jakobsson T, Bjorksten B, Oldaeus G, Jenmalm MC,. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol 2013; 24: 556-561.
18. Taylor AL, Dunstan JA, Prescott SL,. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119: 184-191.
19. Prescott SL, Wiltschut J, Taylor A, et al,. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008; 63: 1481-1490.
20. Jensen MP, Meldrum S, Taylor AL, Dunstan JA, Prescott SL,. Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol 2012; 130: 1209-1211.e5.
21. Wickens K, Black PN, Stanley TV, et al,. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122: 788-794.
22. Wickens K, Black P, Stanley TV, et al,. A protective effect of lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42: 1071-1079.
23. Wickens K, Stanley TV, Mitchell EA, et al,. Early supplementation with lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy 2013; 43: 1048-1057. doi: 10.1111/cea.12154.
24. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R,. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of lactobacillus GG supplementation. Pediatrics 2008; 121: e850-e856.
25. Niers L, Martin R, Rijkers G, et al,. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64: 1349-1358.
26. Soh SE, Aw M, Gerez I, et al,. Probiotic supplementation in the first 6 months of life in at risk asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39: 571-578.
27. West CE, Hammarstrom ML, Hernell O,. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20: 430-437. doi: 10.1111/j.1399-3038.2009.00745.x.
28. West CE, Hammarstrom ML, Hernell O,. Probiotics in primary prevention of allergic disease-follow-up at 8-9 years of age. Allergy 2013; 68: 1015-1020.
29. Kim JY, Kwon JH, Ahn SH, et al,. Effect of probiotic mix (bifidobacterium bifidum, bifidobacterium lactis, lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21 (2pt2): e386-e393.
30. Dotterud CK, Storro O, Johnsen R, Oien T,. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163: 616-623. doi: 10.1111/j.1365-2133.2010.09889.x.
31. Boyle RJ, Ismail IH, Kivivuori S, et al,. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011; 66: 509-516.
32. Ou CY, Kuo HC, Wang L, et al,. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy 2012; 42: 1386-1396.
33. Doege K, Grajecki D, Zyriax BC, Detinkina E,. Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood-a meta-analysis. Br J Nutr 2012; 107: 1-6.
34. Pelucchi C, Chatenoud L, Turati F, et al,. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23: 402-414.
35. Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R,. A half of schoolchildren with 'ISAAC eczema' are ill with allergic contact dermatitis. J Eur Acad Dermatol Venereol 2011; 25: 1104-1107.
36. Yates VM, Kerr RE, MacKie RM,. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis-clinical features. Br J Dermatol 1983; 108: 633-638.
37. Flohr C, Johansson SG, Wahlgren CF, Williams H,. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114: 150-158.
38. Flohr C, Weiland SK, Weinmayr G, et al,. The role of atopic sensitization in flexural eczema: findings from the international study of asthma and allergies in childhood phase two. J Allergy Clin Immunol 2008; 121: 141-147.e4.
39. Hart AL, Lammers K, Brigidi P, et al,. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53: 1602-1609.
40. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H,. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105: 1643-1650.
41. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF,. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145: 612-616.
42. Smits HH, Engering A, van der Kleij D, et al,. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-1267.
43. Viljanen M, Pohjavuori E, Haahtela T, et al,. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005; 115: 1254-1259.
44. Mohrenschlager M, Darsow U, Schnopp C, Ring J,. Atopic eczema: what's new? J Eur Acad Dermatol Venereol 2006; 20: 503-511, 513; quiz 512.
45. Darsow U, Wollenberg A, Simon D, et al,. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 317-328.
46. Ring J, Alomar A, Bieber T, et al,. Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol 2012; 26: 1176-1193.